Ticker Symbol: SGMO

Sangamo Therapeutics Inc

$9.80 - 02-12-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0001001233

Company Profile

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients' lives using gene therapy, cell therapy, and genome engineering.

Sector: Manufacturing

Industry: Biological Product (except Diagnostic) Manufacturing

Standard Industrial Classification Code (SIC code): 2836

Address: 7000 Marina Blvd

Website: www.sangamo.com

CEO: Alexander Macrae

Tags:

Health Technology
Biotechnology
Manufacturing
Biological Product (except Diagnostic) Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST

Previous Close: $0.57

Change: -$0.02 ( -4.75%)

Days Range: $0.56 - $0.60

Beta: 1.65

52wk. High: $4.53

52wk. Low: $0.49

Ytd. Change -85.64%

50 Day Moving Average: $0.71

200 Day Moving Average: $1.13

Shares Outstanding: 177111718

Valuation

Market Cap: 10.1B

PE Ratio: -0.48

EPS (TTM): -1.19

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A